Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy

Background: COVID-19-associated coagulopathy (CAC) exacerbates the course of coronavirus infection and contributes to increased mortality. Current recommendations for CAC treatment include the use of low-molecular weight heparins (LMWH) at prophylactic or therapeutic doses, as well as the use of unf...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliynyk, Oleksandr, Barg, Wojciech, Slifirczyk, Anna, Oliynyk, Yanina, Dubrov, Serhij, Gurianov, Vitaliy, Rorat, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537389/
https://www.ncbi.nlm.nih.gov/pubmed/34685403
http://dx.doi.org/10.3390/life11101032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537389/
https://www.ncbi.nlm.nih.gov/pubmed/34685403
http://dx.doi.org/10.3390/life11101032

Ejemplares similares